KELER TIBOR Insider Trades

Insider Trading History

Track insider trading activity for KELER TIBOR. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Celldex Therapeutics
Celldex Therapeutics CLDX
EXECUTIVE VP & CSO
Holding Value $4.41M 115,000 shares
Last Trade
Jun 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.92M 115,000 shares
$34.09
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
EXECUTIVE VP & CSO
Holding Value $3.56M 93,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.82M 93,000 shares
$19.53
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
EXECUTIVE VP & CSO
Holding Value $3.56M 93,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.39M 93,000 shares
$36.43
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
EXECUTIVE VP & CSO
Holding Value $3.52M 92,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.39M 92,000 shares
$36.87
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director, EXECUTIVE VP & CSO
Holding Value $928k 24,217 shares
Last Trade
Dec 07, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$626k 16,860 shares
$37.10
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director, EXECUTIVE VP & CSO
Holding Value $282k 7,357 shares
Last Trade
Dec 07, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$623k 16,860 shares
$36.93
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director, EXECUTIVE VP & CSO
Holding Value $1.65M 43,140 shares
Last Trade
Dec 07, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$626k 16,860 shares
$37.10
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director, EXECUTIVE VP & CSO
Holding Value $3.49M 91,000 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.05M 91,000 shares
$22.48
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $3.49M 91,000 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.55M 91,000 shares
$28.00
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $4.14M 108,000 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 108,000 shares
$10.38
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $282k 7,357 shares
Last Trade
Jun 09, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15k 5,000 shares
$2.99
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $2.3M 60,000 shares
Last Trade
Jun 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 60,000 shares
$2.78
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $1.35M 35,368 shares
Last Trade
Jun 15, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$144k 16,500 shares
$8.75
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $14.9M 390,000 shares
Last Trade
Jun 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.52M 390,000 shares
$9.02
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $6.21M 162,000 shares
Last Trade
Jun 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.64M 162,000 shares
$34.80
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $723k 18,868 shares
Last Trade
Sep 02, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$151k 3,000 shares
$50.25
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $6.21M 162,000 shares
Last Trade
Jun 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5M 162,000 shares
$70.80
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CSO
Holding Value $4.46M 116,500 shares
Last Trade
Jun 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.4M 116,500 shares
$381.15
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CSO
Holding Value $4.46M 116,500 shares
Last Trade
Jun 04, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.5M 116,500 shares
$201.75
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CSO
Holding Value $4.41M 115,000 shares
Last Trade
Jul 01, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.2M 115,000 shares
$245.40
$38.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up